Literature DB >> 9431548

The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.

M Filip1, E Przegaliński.   

Abstract

The role of dopamine (DA) receptor subtypes in the discriminative stimuli of the psychostimulant drugs of abuse amphetamine and cocaine was evaluated by the ability of DA D1, D2 and D3 receptor subtype ligands to either substitute for or antagonize these effects. Separate groups of rats were trained to discriminate between amphetamine (0.5 mg/kg) and saline, and between cocaine (5 mg/kg) and saline. Both the training drugs evoked cross-substitution. In further substitution experiments, (+)-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H -3-benzazepine (SKF 38393; 5-20 mg/kg), a selective D1 agonist, moderately substituted for cocaine, but not for amphetamine. The D2 agonist bromocriptine (2.5-20 mg/kg) mimicked both training drugs' cues. Pramipexole, a D3-preferring agonist, in a dose of 0.5 mg/kg induced over 80% substitution for cocaine, and a weaker one (ca. 62%) for amphetamine. Combination tests with DA antagonists showed that the D1 antagonist (+)-3-methyl-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H -3-benzazepine (SCH 23390; 0.01-2 mg/kg), and the D2 blocker raclopride (0.13-1 mg/kg) significantly (78-100%) attenuated the effects of psychostimulants, while the D3-preferring antagonist cis-(+)-5-methoxy-1-methyl-2-(di-n-propylamino)tetralin (UH 232; 5-20 mg/kg) did not affect them. The present results indicate a critical role of D2 receptor subtypes in the discriminative stimuli of amphetamine and cocaine in rats, as well as a less pronounced involvement of D1 and D3 subtypes in the effects under study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431548

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  6 in total

1.  Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.

Authors:  Marcello Solinas; Gianluigi Tanda; Carrie E Wertheim; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

2.  Lack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in rats.

Authors:  Gregory T Collins; Paul Butler; Chris Wayman; Sian Ratcliffe; Paul Gupta; Geoffrey Oberhofer; S Barak Caine
Journal:  Behav Pharmacol       Date:  2012-06       Impact factor: 2.293

3.  Effects of dopamine D(2)-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition.

Authors:  Gregory T Collins; Jonathan A Jackson; Wouter Koek; Charles P France
Journal:  Eur J Pharmacol       Date:  2014-02-20       Impact factor: 4.432

4.  Brain-derived neurotrophic factor signaling modulates cocaine induction of reward-associated ultrasonic vocalization in rats.

Authors:  Stacey N Williams; Ashiwel S Undieh
Journal:  J Pharmacol Exp Ther       Date:  2009-10-20       Impact factor: 4.030

Review 5.  Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.

Authors:  Sally L Huskinson; Jennifer E Naylor; James K Rowlett; Kevin B Freeman
Journal:  Neuropharmacology       Date:  2014-03-22       Impact factor: 5.250

6.  Interactions of cocaine with dopamine D₂-like antagonists in squirrel monkeys.

Authors:  Paul L Soto; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.